JHLJapan Handball League
JHLJa Hyvinvointialojen Liitto (Finnish: Public and Welfare Sectors Union; Finland)
JHLJournal of Human Lactation
JHLJess Heavy Lifter (aviation)
JHLJ Hvidtved Larsen A/S (sewer cleaning tankers manufacturer)
JHLJapan House-Reproduction Laboratory
JHLJournal of the House of Lords (official publication; UK)
JHLJabr Ibn Hayan Laboratories (Iran)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
A similar situation was also observed in the upgradation of the JHL Cardiac and Neurosurgery departments.
In its correspondence to JHL, the EMA confirmed it agrees with JHL's development approach, clinical development proposal, and study design of the global Phase III clinical study for JHL1149 in patients with non-small cell lung cancer (NSCLC).
Sanofi will invest $80 million in newly issued JHL shares and will make an upfront payment of $21 million to acquire exclusive rights for the proposed biosimilar of Rituximab and options to certain JHL pipeline products.
* The report provides brief overview of JHL Biotech, Inc.
JHL was undertaking a six-month irrigation canal project that was supposed to be finished this month.
JHL, which specialises in bioengineering and innovative product development technologies, will use the proceeds from the funding round to develop its proprietary biosimilar monoclonal antibody pipeline and step up its filing of investigational new drug applications.
JHL is an innovator in biopharmaceuticals that utilizes breakthrough engineering and process technologies to provide high quality, affordable biosimilar medicines.
Racho Jordanov, JHL Biotech's co-chairman and CEO, said, 'This study adds to the data collected in the JHL1101 EU study and will differentiate JHL from many of its competitors.
According to the company's co-chairman and CEO Racho Jordanov, the study adds to the data collected in the JHL1101 EU study and will differentiate JHL from many of its competitors.
JHL Biotech announced today that the Center for Drug Evaluation (CDE), State Drug Administration of China (SDA) has approved JHL's Phase I and Phase III Clinical Trial Application for a proposed rituximab biosimilar, JHL1101, to treat non-Hodgkin lymphoma.
Biopharmaceutical startup JHL Biotech announced on Wednesday the completion of USD106m convertible bond issuance, with Ion Pacific as sole financial advisor.
JHL Biotech, a biopharmaceutical startup, has named Ellis Chu as its new Chief Financial Officer, effective May 2018, it was reported yesterday.